VJHemOnc is committed to improving our service to you

ERIC 2020 | CLL treatment: discussing new data from the last 3 years

VJHemOnc is committed to improving our service to you

Arnon Kater

Arnon Kater, MD, PhD, University of Amsterdam, Amsterdam, The Netherlands, discusses the importance of being able to debate new research. Over the last 3 years, there has been a large number of clinical trials that have changed the treatment paradigm. Due to each country’s different regulations, it is important to discuss chronic lymphocytic leukemia (CLL) treatment. This interview was recorded during an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter